Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

1.8K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.0K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

836
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
836
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

969
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
969
Cancer02:18

Cancer

53.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shakuntala and the Ring of Recollection: A Lesson in the Theater of Memory and Wisdom.

Practical radiation oncology·2025
Same author

Mortality Review Committee: Understanding Inpatient and 30-Day Mortality at a Comprehensive Cancer Center.

Journal of palliative medicine·2024
Same author

Process Modeling a Radiation Oncology Clinic Workflow From Therapeutic Simulation to Treatment: Identifying Impending Strain and Possible Treatment Delays.

Advances in radiation oncology·2023
Same author

In Regard to Cunningham et al.

International journal of radiation oncology, biology, physics·2023
Same author

In Regard to Ennis.

Practical radiation oncology·2023
Same author

The Gold Ring.

Practical radiation oncology·2021

Related Experiment Video

Updated: Jan 21, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

17.1K

Cancer cachexia and treatment toxicity.

Shilpa Mukunda Chowdhry1, Varun Kumar Chowdhry2

  • 1Department of Geriatrics and Palliative Medicine, State University of New York at Buffalo.

Current Opinion in Supportive and Palliative Care
|August 8, 2019
PubMed
Summary

Cancer cachexia, a metabolic issue causing muscle loss, impacts treatment side effects and outcomes. While often irreversible, nutritional interventions may offer some benefits for patients with cancer.

More Related Videos

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
03:40

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome

Published on: April 25, 2025

1.1K
Vegetated Treatment Systems for Removing Contaminants Associated with Surface Water Toxicity in Agriculture and Urban Runoff
08:49

Vegetated Treatment Systems for Removing Contaminants Associated with Surface Water Toxicity in Agriculture and Urban Runoff

Published on: May 15, 2017

11.1K

Related Experiment Videos

Last Updated: Jan 21, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

17.1K
Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
03:40

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome

Published on: April 25, 2025

1.1K
Vegetated Treatment Systems for Removing Contaminants Associated with Surface Water Toxicity in Agriculture and Urban Runoff
08:49

Vegetated Treatment Systems for Removing Contaminants Associated with Surface Water Toxicity in Agriculture and Urban Runoff

Published on: May 15, 2017

11.1K

Area of Science:

  • Oncology
  • Metabolic Disorders
  • Nutritional Science

Background:

  • Cancer cachexia is a complex metabolic disturbance characterized by significant skeletal muscle mass loss.
  • This condition is frequently resistant to conventional nutritional support.
  • It affects patients across various cancer types and treatment modalities.

Purpose of the Study:

  • To review the impact of nutritional status on cancer treatment side effects.
  • To examine the influence of nutritional status on cancer-specific outcomes.
  • To explore the potential role of nutritional interventions in managing cancer cachexia.

Main Methods:

  • Literature review of existing studies on cancer cachexia and nutritional status.
  • Analysis of the relationship between nutritional status and treatment toxicity.
  • Evaluation of evidence for nutritional interventions in cancer patients.

Main Results:

  • Cancer cachexia and sarcopenia are linked to increased treatment toxicity and poorer outcomes in surgical, chemotherapeutic, and radiotherapeutic populations.
  • Despite the general perception of irreversibility, some evidence suggests nutritional interventions can be beneficial.
  • Poor nutritional status is a critical factor influencing cancer therapy and patient outcomes.

Conclusions:

  • Nutritional status is a key determinant in cancer therapy planning and management.
  • Early identification and close monitoring of patients with poor nutritional status are essential.
  • While challenging, nutritional interventions may play a supportive role in mitigating the effects of cancer cachexia.